StockData
BioAdaptives, Inc. logo

BioAdaptives, Inc. (BDPT) stock

BDPTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.00−0.00 (-5.56%)

Close on Oct 19, 2026Market cap $478.03KP/E –Yield –

BioAdaptives gross margin

Gross margin is gross profit as a percentage of revenue.

BioAdaptives's gross margin for the twelve months ending Jun 30, 2026 was 77.4%. For fiscal 2025 it was 68.4%, against 31.8% the year before. The highest annual figure on record is 68.4% in fiscal 2025.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202568.4%+36.6
FY2024Dec 31, 202431.8%−6.1
FY2023Dec 31, 202337.9%−3.6
FY2022Dec 31, 202241.5%−9.6
FY2021Dec 31, 202151.1%+13.8
FY2020Dec 31, 202037.3%−11.8
FY2019Dec 31, 201949.2%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202685.0%+52.0
Q1 FY2026Mar 31, 202674.6%+11.0
Q4 FY2025Dec 31, 202572.7%+42.7
Q3 FY2025Sep 30, 202583.1%+45.7
Q2 FY2025Jun 30, 202533.0%+3.3
Q2 FY2024Jun 30, 202463.6%−0.1
Q1 FY2024Mar 31, 202430.0%−28.6
Q4 FY2023Dec 31, 202337.5%+11.6
Q3 FY2023Sep 30, 202329.7%−30.2
Q2 FY2023Jun 30, 202363.7%+13.9
Q1 FY2023Mar 31, 202358.6%+23.5
Q4 FY2022Dec 31, 202225.9%−3.8
Q3 FY2022Sep 30, 202259.9%+1.6
Q2 FY2022Jun 30, 202249.8%−5.5
Q1 FY2022Mar 31, 202235.1%−20.1
Q4 FY2021Dec 31, 202129.7%−13.3
Q3 FY2021Sep 30, 202158.3%+34.6
Q2 FY2021Jun 30, 202155.3%+51.1
Q1 FY2021Mar 31, 202155.2%−15.5
Q4 FY2020Dec 31, 202043.0%+184.5
Q3 FY2020Sep 30, 202023.7%−55.4
Q2 FY2020Jun 30, 20204.2%−67.1
Q1 FY2020Mar 31, 202070.7%−7.1
Q4 FY2019Dec 31, 2019-141.6%−192.7
Q3 FY2019Sep 30, 201979.0%–
Q2 FY2019Jun 30, 201971.3%–
Q1 FY2019Mar 31, 201977.8%–
Q3 FY2016Sep 30, 201651.2%–

More BioAdaptives figures

See a number that looks wrong?